Back to Search
ELENI EFSTATHIOU, M.D.
M.D.
Medical Oncology Physician
NPI: 1447654470IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
44660(TX)
Education
OTHER
Class of 1995
Research & Publications (20)
Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer.
PMID 17317833·Clin Cancer Res·2007
3-trial
Review of late complications of treatment and late relapse in testicular cancer.
PMID 17112453·J Natl Compr Canc Netw·2006
6-review
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.
PMID 19244175·J Natl Cancer Inst·2009
3-trial
RANKL inhibition: clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases.
PMID 19344283·Expert Opin Biol Ther·2009
6-review
Prostate cancer: thalidomide for prostate cancer: is there progress?
PMID 19424170·Nat Rev Urol·2009
8-other
Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data.
PMID 19653896·BMC Med Genomics·2009
8-other
Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
PMID 19337169·Pediatr Endocrinol Rev·2008
2-rct
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial.
PMID 18026149·Bone Marrow Transplant·2008
3-trial
Hormonal dysregulation and bones in thalassaemia--an overview.
PMID 19337163·Pediatr Endocrinol Rev·2008
6-review
Association between family divorce and children's BMI and meal patterns: the GENDAI Study.
PMID 18369339·Obesity (Silver Spring)·2008
8-other
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.
PMID 18618013·J Clin Invest·2008
7-preclinical
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesis.
PMID 19018165·Cancer Biol Ther·2008
8-other
Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma.
PMID 17052747·Gynecol Oncol·2007
3-trial
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
PMID 16999858·BMC Cancer·2006
8-other
Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience.
PMID 16899981·Oncology·2006
4-observational
Comparison of angiogenic activity after urethral reconstruction using free grafts and pedicle flap: an experimental study.
PMID 17160776·Eur J Pediatr Surg·2006
4-observational
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
PMID 15863142·Gynecol Oncol·2005
8-other
The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
PMID 16051322·Gynecol Oncol·2005
8-other
Late relapse of epithelial ovarian cancer: a single institution experience.
PMID 16122198·Eur J Gynaecol Oncol·2005
8-other
Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
PMID 16322299·Clin Cancer Res·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1447654470
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile